NCT02600949 2026-04-21
Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer
M.D. Anderson Cancer Center
Phase 1 Recruiting
M.D. Anderson Cancer Center
University of Southern California
Baylor College of Medicine
OX2 Therapeutics